Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intradiscal rhGDF-6 for Lumbar Disc Degeneration
NCT07668466Phase 2Not yet recruiting
- Sponsor
- Cartago Biotech
- Start
- Jul 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 2, open-label trial in Lumbar degenerative disc disease (DDD) and back pain (2 arms), sponsored by Cartago Biotech. Primary endpoints: Neurological Status at 12 months and Oswestry Disability Index at 12 months. Planned start Jul 2026; status: not yet recruiting.
02
Conditions
Lumbar degenerative disc disease (DDD)back pain
Beyond the preview
Go deeper on NCT07668466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07668466.